Hepion Pharmaceuticals Inc (HEPA)

Apr 01, 2025

Before You Invest, Make Sure You Check This Hepion Pharmaceuticals Inc (NASDAQ: HEPA) Analysis - stocksregister.com

Apr 01, 2025

Apr 01, 2025

Hepion Pharmaceuticals Delays Annual Report Filing - TipRanks

Apr 01, 2025

Mar 28, 2025

Hepion Pharmaceuticals announces 1-for-50 reverse stock split - MSN

Mar 28, 2025

Mar 25, 2025

HEPA stock plunges to 52-week low, touches $0.67 By Investing.com - Investing.com UK

Mar 25, 2025

Mar 25, 2025

Hepion Pharmaceuticals (NASDAQ:HEPA) Stock Price Down 7.2% – Here’s Why - Defense World

Mar 25, 2025

Mar 21, 2025

Hepion Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 20, 2025

Hepion Pharmaceuticals faces potential Nasdaq delisting - Investing.com

Mar 20, 2025

Mar 19, 2025

Hepion Pharmaceuticals enacts reverse stock split - Investing.com

Mar 19, 2025

Mar 17, 2025

Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split Effective March 17, 2025 - Nasdaq

Mar 17, 2025

Mar 17, 2025

Upcoming Stock Splits This Week (March 17 to March 21) – Stay Invested - The Globe and Mail

Mar 17, 2025

Mar 14, 2025

Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split - ROI-NJ.com

Mar 14, 2025

Mar 14, 2025

Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split To Maintain Nasdaq Listing - Nasdaq

Mar 14, 2025

Mar 14, 2025

Hepion Pharmaceuticals enacts reverse stock split to meet NASDAQ requirements - Investing.com Australia

Mar 14, 2025

Mar 14, 2025

Hepion Pharmaceuticals enacts reverse stock split to meet NASDAQ requirements By Investing.com - Investing.com South Africa

Mar 14, 2025

Mar 14, 2025

Hepion Pharmaceuticals Announces Reverse Stock Split - citybiz

Mar 14, 2025

Mar 14, 2025

Hepion Plans Massive 1:50 Reverse Split to Save NASDAQ ListingWhat Shareholders Must Know - StockTitan

Mar 14, 2025

Mar 13, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mar 13, 2025

Mar 13, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Mar 13, 2025

Mar 13, 2025

Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga India

Mar 13, 2025

Mar 12, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Mar 12, 2025

Mar 11, 2025

An In-Depth Look At Hepion Pharmaceuticals Inc (HEPA) - Marketing Sentinel

Mar 11, 2025

Mar 10, 2025

HEPA stock plunges to 52-week low, touches $0.08 By Investing.com - Investing.com Australia

Mar 10, 2025

Mar 10, 2025

HEPA stock plunges to 52-week low, touches $0.08 - Investing.com

Mar 10, 2025

Mar 05, 2025

Hepion Pharmaceuticals releases unaudited balance sheet - Investing.com India

Mar 05, 2025

Mar 01, 2025

Hepion Pharmaceuticals Announces Publication in Expert Opinion on Investigational Drugs - ACCESS Newswire

Mar 01, 2025

Feb 28, 2025

HEPA stock touches 52-week low at $0.12 amid sharp decline - Investing.com Canada

Feb 28, 2025

Feb 27, 2025

Hepion Pharmaceuticals Successfully Advances to Next Dosing Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431 - ACCESS Newswire

Feb 27, 2025

Feb 11, 2025

Hepion Pharmaceuticals (NASDAQ:HEPA) Shares Up 1.3% – Here’s Why - Defense World

Feb 11, 2025

Feb 10, 2025

The HEPA Stock Puzzle: Unraveling Hepion Pharmaceuticals Inc’s Fluctuating Performance - The InvestChronicle

Feb 10, 2025

Feb 10, 2025

A look at HEPA’s current quarter earnings estimates - US Post News

Feb 10, 2025

Feb 10, 2025

Evaluating the Impact of 3.43 Increase on Hepion Pharmaceuticals Inc’s (HEPA) Stock - The News Heater

Feb 10, 2025

Feb 10, 2025

Gaining Ground: Hepion Pharmaceuticals Inc (HEPA) Closes Higher at 0.17, Up 3.43 - The Dwinnex

Feb 10, 2025

Feb 07, 2025

Form DEF 14A Hepion Pharmaceuticals, For: Feb 07 - StreetInsider.com

Feb 07, 2025

Feb 04, 2025

An analyst sees good growth prospects for Hepion Pharmaceuticals Inc (HEPA) - SETE News

Feb 04, 2025

Feb 03, 2025

Hepion Pharmaceuticals Inc (HEPA) Stock: A Year of Decreases and Increases - The InvestChronicle

Feb 03, 2025

Feb 03, 2025

Understanding HEPA’s financial ratios: A beginner’s guide - US Post News

Feb 03, 2025

Jan 30, 2025

Metabolic Dysfunction-Associated Steatohepatitis Market to Register Stunning Growth at a CAGR of 17.9% in the US by 2034 | DelveInsight - PR Newswire

Jan 30, 2025

Jan 28, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Jan 28, 2025

Jan 28, 2025

Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 28, 2025

Jan 24, 2025

Hepion Pharmaceuticals to Participate in BIO CEO & Investor Digital Conference - ACCESS Newswire

Jan 24, 2025

Jan 24, 2025

Hepion Announces Closing of Public Offering of Common Stock - ACCESS Newswire

Jan 24, 2025

Jan 24, 2025

12 Health Care Stocks Moving In Friday's Pre-Market SessionAclarion (NASDAQ:ACON), Alumis (NASDAQ:ALMS) - Benzinga

Jan 24, 2025

Jan 23, 2025

Hepion Pharmaceuticals launches public offering for proceeds of up to $9M; shares tumble - MSN

Jan 23, 2025

Jan 22, 2025

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales - Benzinga

Jan 22, 2025

Jan 22, 2025

Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings - Benzinga

Jan 22, 2025

Jan 22, 2025

Stock market today: Star Fashion Culture Holdings jumped by 680.92% while Hepion Pharmaceuticals saw increase of 147.54% in early trading - Business Upturn

Jan 22, 2025

Jan 22, 2025

Hepion Pharmaceuticals launches $9 million stock offering - Investing.com India

Jan 22, 2025

Jan 22, 2025

Hepion Pharmaceuticals announces $9M public offering - TipRanks

Jan 22, 2025

Jan 22, 2025

Hepion Pharmaceuticals Announces $9.0 Million Public Offering - The Manila Times

Jan 22, 2025

Jan 22, 2025

Hepion Pharmaceuticals Announces $9M Public Offering with Dual Warrant Structure - StockTitan

Jan 22, 2025

Jan 15, 2025

HEPA stock touches 52-week low at $0.43 amid market challenges - Investing.com India

Jan 15, 2025